title: The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5.
abstract: Transforming growth factor-beta (TGF beta) has been shown to influence the growth and differentiation of many widely varied cell types in vitro, including some that are endocrinologically active. We have investigated the previously unknown effects of this unique growth factor in the differentiated rat thyroid follicular cell line FRTL-5. The cells demonstrated specific, high affinity binding of TGF beta, and as with other epithelial cells, the growth of these thyroid follicular cells was potently inhibited by addition of TGF beta to the culture medium. TGF beta caused a significant reduction in TSH-sensitive adenylate cyclase activity in the cells. The addition of (Bu)2cAMP along with the growth factor to cultures partially reversed the characteristic morphological changes seen with TGF beta, but did not reverse the growth inhibition. To further investigate the possible mechanisms of the effects of TGF beta on the cells, we measured the influence of the growth factor on [125I]TSH binding. TGF beta did not compete for specific TSH-binding sites; however, exposure of the cells to TGF beta for 12 or more h resulted in a dose-dependent down-regulation of TSH receptors that was fully reversible. While cellular proliferation was potently inhibited by TGF beta, differentiated function, as manifest by iodine-trapping ability, was stimulated by the growth factor. This stimulation of iodine uptake was independent of, and additive to, the stimulatory effects of TSH. Finally, FRTL-5 cells in serum-free medium and in response to TSH were shown to secrete TGF beta-like activity that competed for [125I]TGF beta in a RRA. These studies suggest that TGF beta may represent an autocrine mechanism of controlling the growth response to TSH in thyroid follicular cells, while allowing the continuance of differentiated function.
authors.affiliation: Division of Endocrinology and Internal Medicine, Mayo Clinic and Medical Center, Rochester, Minnesota 55905.
authors.forename: J C
authors.initials: JC
authors.lastname: Morris
authors.forename: G
authors.initials: G
authors.lastname: Ranganathan
authors.forename: I D
authors.initials: ID
authors.lastname: Hay
authors.forename: R E
authors.initials: RE
authors.lastname: Nelson
authors.forename: N S
authors.initials: NS
authors.lastname: Jiang
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D006133:Growth Substances / Q000494:pharmacology*; D007454:Iodides / Q000378:metabolism; D007457:Iodine Radioisotopes; D007700:Kinetics; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D011989:Receptors, Thyrotropin / Q000378:metabolism; D013961:Thyroid Gland / Q000166:cytology* / Q000187:drug effects; D013972:Thyrotropin / Q000378:metabolism; D015291:Transforming Growth Factors
chemical_list: D006133:Growth Substances; D007454:Iodides; D007457:Iodine Radioisotopes; D010455:Peptides; D011989:Receptors, Thyrotropin; D015291:Transforming Growth Factors; D013972:Thyrotropin; D000262:Adenylyl Cyclases